Smoking characteristics among lesbian, gay, and bisexual adults A Fallin, A Goodin, YO Lee, K Bennett Preventive medicine 74, 123-130, 2015 | 127 | 2015 |
Rural and Appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment JD Brown, AJ Goodin, JC Talbert The Journal of rural health 34 (1), 6-13, 2018 | 111 | 2018 |
Menthol cigarette smoking among lesbian, gay, bisexual, and transgender adults A Fallin, AJ Goodin, BA King American journal of preventive medicine 48 (1), 93-97, 2015 | 93 | 2015 |
Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing PR Freeman, A Goodin, SZ Troske, A Strahl, A Fallin, TC Green Journal of the American Pharmacists Association 57 (2), S28-S33, 2017 | 84 | 2017 |
Online medical care: the current state of “eVisits” in acute primary care delivery R Hickson, J Talbert, WC Thornbury, NR Perin, AJ Goodin Telemedicine and e-Health 21 (2), 90-96, 2015 | 82 | 2015 |
Risk stratification for bleeding complications in patients with venous thromboembolism: application of the HAS‐BLED bleeding score during the first 6 months of anticoagulant … JD Brown, AJ Goodin, GYH Lip, VR Adams Journal of the American Heart Association 7 (6), e007901, 2018 | 80 | 2018 |
Characteristics of older adults who were early adopters of medical cannabis in the Florida Medical Marijuana Use Registry JD Brown, B Costales, S van Boemmel-Wegmann, AJ Goodin, R Segal, ... Journal of clinical medicine 9 (4), 1166, 2020 | 52 | 2020 |
Mass casualty shooting venues, types of firearms, and age of perpetrators in the United States, 1982–2018 JD Brown, AJ Goodin American journal of public health 108 (10), 1385-1387, 2018 | 46 | 2018 |
Changes in opioid use after Florida’s restriction law for acute pain prescriptions JM Hincapie-Castillo, A Goodin, MC Possinger, SA Usmani, SM Vouri JAMA Network Open 3 (2), e200234-e200234, 2020 | 45 | 2020 |
Healthcare utilization and physical functioning in older adults in the United States Y Cheng, AJ Goodin, M Pahor, T Manini, JD Brown Journal of the American Geriatrics Society 68 (2), 266-271, 2020 | 44 | 2020 |
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population A Goodin, K Blumenschein, PR Freeman, J Talbert Pain physician 15 (3 Suppl), ES169, 2012 | 41 | 2012 |
Prescription drug monitoring program utilization in Kentucky community pharmacies SE Wixson, K Blumenschein, AJ Goodin, J Talbert, PR Freeman Pharmacy practice 13 (2), 2015 | 37 | 2015 |
Principles of research design and drug literature evaluation RR Aparasu, JP Bentley Jones & Bartlett Publishers, 2014 | 37 | 2014 |
Pharmacists’ role in harm reduction: a survey assessment of Kentucky community pharmacists’ willingness to participate in syringe/needle exchange A Goodin, A Fallin-Bennett, T Green, PR Freeman Harm reduction journal 15, 1-9, 2018 | 35 | 2018 |
A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019 S Jugl, A Okpeku, B Costales, EJ Morris, G Alipour-Haris, ... Medical Cannabis and Cannabinoids 4 (1), 21-42, 2021 | 34 | 2021 |
Large expert-curated database for benchmarking document similarity detection in biomedical literature search P Brown, Y Zhou Database 2019, baz085, 2019 | 34 | 2019 |
Smoking cessation awareness and utilization among lesbian, gay, bisexual, and transgender adults: an analysis of the 2009–2010 National Adult Tobacco Survey A Fallin, YO Lee, K Bennett, A Goodin Nicotine & Tobacco Research 18 (4), 496-500, 2015 | 29 | 2015 |
Kentucky house bill 1 impact evaluation PR Freeman, A Goodin, S Troske, J Talbert Institute for Pharmaceutical Outcomes and Policy: University of Kentucky, 2015 | 27 | 2015 |
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009–2014 Y Shen, WH Lo-Ciganic, R Segal, AJ Goodin Journal of Psychosomatic Obstetrics & Gynecology, 1-7, 2020 | 26 | 2020 |
Natural and synthetic cannabinoids: pharmacology, uses, adverse drug events, and drug interactions JD Brown, KJ Rivera Rivera, LYC Hernandez, MR Doenges, I Auchey, ... The Journal of Clinical Pharmacology 61, S37-S52, 2021 | 25 | 2021 |